Delivery Order SPE2DB24D2100-SPE2DB25FBGHE
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of ZORYVE 0.3% Foam in 60-gram units, with a contract ceiling value of $1,242.98. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4,...
- The Defense Logistics Agency awarded a $2,870.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam in a 60-gram unit, with an ultimate completion date of August 13, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM pharmaceutical product, valued at $2,424.17 under a firm fixed-price contract type. This non-set-aside award was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a child contract under a larger vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,092.43 to supply ZORYVE 0.3% Foam in 60-gram units. This contract represents a child delivery order under a larger indefinite delivery contract vehicle, utilizing firm fixed-price pricing with no set-aside designation. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ZORYVE 0.3% Foam 60GM, a topical dermatological medication. This firm fixed price delivery order, valued at $1,158.98, represents a non-set-aside competitive award with an ultimate completion date of August 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,161.02 to AmerisourceBergen Drug Corp for ZORYVE 0.3% Foam 60GM, a topical pharmaceutical product. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division as a child delivery order under a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a ceiling value of $1,983.94 and a performance period extending through May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation,...
- This delivery order, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp on August 5, 2025, provides $1,113.09 in firm fixed price funding for ZORYVE 0.3% Foam 60gm, a pharmaceutical product to be delivered to the Conshohocken, Pennsylvania location with completion targeted for August 6, 2025. The award represents a non-competitive delivery order issued under an existing contract vehicle, reflecting DLA's established relationship with AmerisourceBergen as a critical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract has a ceiling value of $1,533.42 and runs through April 15, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,352.87 firm fixed-price delivery order is for the supply of ZORYVE 0.3% foam, a pharmaceutical product, with a period of performance through May 9, 2025. The award is not associated with a set-aside program and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...